Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF (SCENIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03864328
Recruitment Status : Terminated (COVID-19 Pandemic)
First Posted : March 6, 2019
Last Update Posted : June 11, 2020
Sponsor:
Collaborator:
Respivant Sciences Inc.
Information provided by (Responsible Party):
Respivant Sciences Inc. ( Respivant Sciences GmbH )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : May 29, 2020
Actual Study Completion Date : June 5, 2020